Voxelotor
14.8K
Volume
+90%
Growth
regular
About the Topic
Medication used in the treatment of sickle cell disease by increasing the affinity of hemoglobin for oxygen, thereby reducing the sickling of red blood cells and improving their lifespan. Approved by the U.S. Food and Drug Administration (FDA) in November 2019, it helps alleviate symptoms and complications such as pain crises and anemia. Primarily targeted at patients aged 12 years and older suffering from sickle cell disease.
Voxelotor was discovered on July 20th 2019 and it currently has a search volume of 14.8K with a growth of +90%.
Key Indicators
Growth
- Exploding
- Regular
- Peaked
Speed
- Exponential
- Constant
- Stationary
Seasonality
- High
- Medium
- Low
Volatility
- High
- Average
- Low
Members Only
Try Exploding Topics Pro
Get Free, Unlimited Access for 7 Days.
Categories
Save this topic and build your own trend dashboard.
Available with Exploding Topics Pro, try it now.
1.1M+ trends in our growing database.